Saturday 17 October 2026 Export BYND’s income statement to Excel — free account

Beyond Meat, Inc.

Beyond Meat, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $275.5 million, down 15.6% from fiscal 2024. In the quarter to June 2026, revenue fell 8.17%, EPS grew 107.0%, free cash flow grew 44.6% and total debt fell 70.7%, each against the same quarter a year earlier.

6.85 0.32 −4.46%

Follow BYND

Alert me

Market cap: $131.2M
P/E: 0.0×
Fwd P/E: −2.5×
Dividend yield: —
F-score: 3/9
Altman Z: −3.03
Beneish M: 1.96
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.28

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	1	—	—	—	2	—	—	—	—	—	—

Insider Ownership 1.82%

Capital & Financial Ratios $m

Market Cap 131.15

Revenue 258.85

Net Income 299.88

Free Cash Flow (116.49)

Net Debt 196.09

Current Ratio 2.63

Debt/Equity 6.57

P/E ratio 0.00

Fwd P/E (2.47)

P/S ratio 0.44

P/B ratio 2.01

Past 5Y EPS Growth —

This Y EPS Growth 83.04%

Next Y EPS Growth 1.17%

Next Y revenue growth (10.89%)

Next 5Y EPS Growth 43.25%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 4.37%

10-year low 10-year high

P/B against its own 10 years 0.24%

10-year low 10-year high

EV/Sales against its own 10 years 0.11%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	193	133	208	177
Receivables	32	27	26	26
Inventory	130	113	84	63
Other	5	2	9	9
	373	286	341	296

	2023	2024	2025	Q'26
Payables	56	38	21	25
ST’ Debt	—	—	—	—
Other	—	—	—	—
	74	61	75	112

Compound Annual Growth %

	10y	5y	3y
Sales	—	(7.50%)	(13.04%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	58	69	—	—	—
’25	69	75	70	62	275
’24	76	93	81	77	326
’23	92	102	75	74	343
’22	109	147	83	80	419
’21	108	149	106	101	465
’20	97	113	94	102	407

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(5)	(18)	—	—	—
’25	(26)	(32)	(40)	(47)	(145)
’24	(32)	(16)	(22)	(29)	(99)
’23	(42)	(46)	9	(29)	(108)
’22	(165)	(70)	(35)	(50)	(320)
’21	(31)	(90)	(71)	(110)	(301)
’20	(17)	(27)	2	3	(40)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(7)	(19)	—	—	—
’25	(30)	(34)	(42)	(49)	(155)
’24	(33)	(15)	(23)	(35)	(105)
’23	(45)	(48)	8	(29)	(114)
’22	(187)	(91)	(53)	(63)	(394)
’21	(54)	(118)	(123)	(142)	(437)
’20	(31)	(42)	(10)	(32)	(115)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.80)	0.83	—	—	—
’25	(20.72)	(12.91)	(43.24)	(8.71)	(55.86)
’24	(25.22)	(15.92)	(12.31)	(19.52)	(72.97)
’23	(27.63)	(24.92)	(32.73)	(72.07)	(157.96)
’22	(47.45)	(45.95)	(48.05)	(31.53)	(172.67)
’21	(12.91)	(9.31)	(26.13)	(38.14)	(86.49)
’20	0.90	(4.80)	(9.31)	(12.01)	(25.53)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	1,350.00	1,445.40	1,861.80	330.90	167.40	99.00	15.00	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	7,191.30	5,925.00	6,630.00	2,220.00	686.10	363.60	230.70
People
People	Employees	—	—	383	472	700	1,419	876	749	808	639
	Revenue/emp, $m	0.00	0.00	0.23	0.63	0.58	0.33	0.48	0.46	0.40	0.43
Income, $m
Income, $m	Revenue	16	33	88	298	407	465	419	343	326	275
	Gross margin, %	(39.01)	(6.72)	19.99	33.49	30.06	25.24	(5.67)	(24.07)	12.77	2.78
	EBT	(25)	(30)	(30)	(12)	(53)	(179)	(347)	(334)	(160)	219
	EBT margin, %	(155.39)	(93.24)	(33.99)	(4.17)	(12.95)	(38.53)	(82.87)	(97.34)	(49.08)	79.53
	Net income	(25)	(30)	(30)	(12)	(53)	(182)	(366)	(338)	(160)	219
	Depreciation	2	3	5	8	14	25	37	52	27	38
Per share, $
Per share, $	Revenue	106.39	179.21	419.93	211.60	196.11	220.91	197.74	160.37	148.52	53.28
	Earnings	(165.37)	(167.17)	(142.75)	(8.71)	(25.53)	(86.49)	(172.67)	(157.96)	(72.97)	34.54
	Cash flow	(154.47)	(139.02)	(180.14)	(33.38)	(19.28)	(143.26)	(151.16)	(50.36)	(44.96)	(28.03)
	Capex	(32.58)	(43.50)	(110.71)	(18.41)	(36.38)	(64.63)	(34.60)	(2.91)	(3.03)	(2.00)
	Free cash flow	(187.05)	(182.51)	(290.85)	(51.79)	(55.66)	(207.90)	(185.75)	(53.27)	(47.99)	(30.04)
	Book value	0.00	287.57	371.49	272.83	176.97	62.98	(96.08)	(239.76)	(273.52)	(0.19)
	Shares, m	0	0	0	1	2	2	2	2	2	5
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	3.97	3.97	3.97	10.72	19.12	8.85	1.88	1.53	0.76	0.46
	P/B	0.00	0.00	0.00	8.31	21.19	31.04	0.00	0.00	0.00	0.00
	EV/Sales	3.96	3.96	3.96	9.90	18.79	9.76	3.91	4.36	3.93	1.60
	EV/FCF	(6.51)	(6.51)	(6.51)	(40.43)	(66.21)	(10.37)	(4.16)	(13.11)	(12.18)	(2.84)
Cash, $m
Cash, $m	Operating cash flow	(23)	(25)	(38)	(47)	(40)	(301)	(320)	(108)	(99)	(145)
	Capex	(5)	(8)	(23)	(26)	(75)	(136)	(73)	(6)	(7)	(10)
	Free cash flow	(28)	(33)	(61)	(73)	(115)	(437)	(394)	(114)	(105)	(155)
Balance, $m
Balance, $m	Working capital	19	40	78	356	243	958	531	298	225	267
	Total debt	3	5	31	31	25	1,130	1,134	1,138	1,144	497
	Net debt	(14)	(34)	(23)	(245)	(134)	397	824	944	1,011	289
	Shareholders’ equity	—	52	78	384	367	132	(204)	(513)	(601)	(1)
Returns, %
Returns, %	ROA	(76.21)	(91.43)	(29.85)	(4.25)	(11.47)	(19.71)	(29.99)	(36.82)	(22.07)	27.54
	ROIC	0.00	(97.80)	(32.21)	(0.22)	(13.23)	(20.66)	(34.52)	(49.57)	(23.79)	(72.36)
	ROE	30.94	37.40	27.46	(9.49)	(14.04)	(72.90)	1,030.60	94.33	28.76	(59.12)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
USNA USANA Health Sciences, Inc.	$284.2M	— (loss-making)	14.0×	−5.33% (below 0%: shrinking)	n/m	+180.61% (above 0%: growing)	78.35%	(8.96%)	Compare
BRCC BRC Inc.	$263.3M	— (loss-making)	43.0×	+12.85% (above 0%: growing)	n/m	+226.39% (above 0%: growing)	34.09%	1.03%	Compare
NATR Nature's Sunshine Products, Inc.	$222.4M	12.4×	16.4×	+1.95% (above 0%: growing)	−31.03% (below 0%: shrinking)	−164.92% (below 0%: shrinking)	73.66%	4.69%	Compare
BGS B&G Foods, Inc.	$196.7M	— (loss-making)	— (loss-making)	−9.70% (below 0%: shrinking)	n/m	+19.28% (above 0%: growing)	20.78%	9.02%	Compare
BYND Beyond Meat, Inc.	$131.2M	— (loss-making)	— (loss-making)	−8.17% (below 0%: shrinking)	n/m	+44.64% (above 0%: growing)	8.53%	(44.76%)
WYHG Wing Yip Food Holdings Group Limited - Sponsored ADR	$111.7M	—	—	—	—	−999.42% (below 0%: shrinking)	—	—	Compare
FTLF FitLife Brands Inc.	$80.5M	12.7×	11.5×	+64.62% (above 0%: growing)	+10.53% (above 0%: growing)	+205.46% (above 0%: growing)	36.95%	12.64%	Compare
LFVN Lifevantage Corporation	$75.5M	15.0×	25.6×	−23.11% (below 0%: shrinking)	−37.50% (below 0%: shrinking)	+346.71% (above 0%: growing)	77.97%	3.93%	Compare
HOST Healthy Choice Wellness Corp.	$70.5M	— (loss-making)	— (loss-making)	−17.77% (below 0%: shrinking)	n/m	−215.75% (below 0%: shrinking)	38.60%	(15.90%)	Compare
Median of peers	$154.2M	12.7×	16.4×	−5.33%	−31.03%	+99.95%	38.60%	3.93%

All 71 Packaged Foods stocks →

Beyond Meat, Inc. (BYND) key facts

Concern: Beyond Meat, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $275.5 million, down 15.6% from fiscal 2024.
Beyond Meat, Inc. (BYND) is a Packaged Foods company in the Consumer Defensive sector, listed on Nasdaq.
As of October 16, 2026, BYND traded at $6.85, a market capitalization of $131.2 million.
Return on equity was −59.1% and debt-to-equity 6.57.
Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −3.03 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.